-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sutro Biopharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q2 2024.
- Sutro Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $8K, a 94.7% decline year-over-year.
- Sutro Biopharma, Inc. annual Income Tax Expense (Benefit) for 2023 was $18.2M, a 628% increase from 2022.
- Sutro Biopharma, Inc. annual Income Tax Expense (Benefit) for 2022 was $2.5M.
- Sutro Biopharma, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)